Log In
Print
BCIQ
Print
Print this Print this
 

Privigen

  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
Description10% formulation of IV immunoglobulin (IVIg)
Molecular Target Fc gamma receptor IIb (CD32B) (FCGR2B)
Mechanism of ActionImmune modulation
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today